Age-Related Macular Degeneration (ARMD) Clinical Trials

Find Age-Related Macular Degeneration (ARMD) Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Direct Discrimination of Quantum States by the Human Eye With Macular Degeneration

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Participants who are clinically diagnosed with a vision disease affecting their macula

• Older adults who are matched for age.

• Participants who are clinically diagnosed with glaucoma

• Participants who have normal vision.

• One aged-matched control with normal vision will be recruited for each of the diagnosed groups (born in the same year).

Locations
Other Locations
Hong Kong Special Administrative Region
Centre for Eye and Vision Research Limited
RECRUITING
Hong Kong
Contact Information
Primary
Benjamin Thompson, PhD
ben.thompson@cevr.hk
+852-3169-9631
Backup
Mukhit Kulmaganbetov, MD, PhD
mukhit.k@cevr.hk
+852-3169-9631
Time Frame
Start Date: 2023-06-26
Estimated Completion Date: 2029-10-01
Participants
Target number of participants: 50
Treatments
Experimental: Participants with Age-Related Macular Degeneration
Conducting the psychophysical task on the perception of OAM-coupled polarized light
Related Therapeutic Areas
Late-Onset Retinal Degeneration
Age-Related Macular Degeneration (ARMD)
Sponsors
Collaborators: The Hong Kong Polytechnic University, University of Waterloo
Leads: Centre for Eye and Vision Research

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

A Phase 3/4, Multicenter, Single-arm Clinical Study to Assess the Safety of Intravitreal Administration of ASP3021 in Participants in Japan With Geographic Atrophy Secondary to Age-related Macular Degeneration

A Phase 3/4, Multicenter, Single-arm Clinical Study to Assess the Safety of Intravitreal Administration of ASP3021 in Participants in Japan With Geographic Atrophy Secondary to Age-related Macular Degeneration

Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Drug
Study Phase: Phase 4

A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability of ASP7317 for Geographic Atrophy Secondary to Age-related Macular Degeneration

A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability of ASP7317 for Geographic Atrophy Secondary to Age-related Macular Degeneration

Who is this study for: Patients with Age Related Macular Degeneration
Enrollment Status: Recruiting
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drugs: ASP7317, Tacrolimus
Study Phase: Phase 1

Village-Integrated Eye Worker Trial II (VIEW II):A Cluster-randomized Trial of the Effectiveness of Community-based Ocular Disease Screening

Village-Integrated Eye Worker Trial II (VIEW II):A Cluster-randomized Trial of the Effectiveness of Community-based Ocular Disease Screening

Who is this study for: Patients with Age-related Macular Degeneration, Diabetic Retinopathy, Glaucoma
Enrollment Status: Recruiting
Publish Date: July 11, 2025
Intervention Type: Other
Study Phase: Not Applicable
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved